Real-world application of targeted next-generation sequencing for identifying molecular variants in Asian non-small-cell lung cancer
This study demonstrates the robust performance of the OFA in identifying clinically relevant genetic alterations in NSCLC. The findings support its clinical utility in precision oncology and provide valuable insights into the genetic landscape of Asian NSCLC, enhancing personalized treatment strategies for lung cancer patients.
Authors
- Fangyu Wang (ORCID: https://orcid.org/0000-0002-6388-1461)
- Paul Chih-Hsueh Chen (ORCID: https://orcid.org/0000-0003-2639-0206)
- Teh‐Ying Chou (ORCID: https://orcid.org/0000-0001-5844-477X)
- Shin-Ying Lin
- Shuying Wang (ORCID: https://orcid.org/0000-0003-3339-8070)
- Hsiang‐Ling Ho
- Yi‐Chen Yeh
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Medical University Hospital (TW)
- Taipei Veterans General Hospital (TW)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1186/s12885-025-14016-z
- Citations
- 6
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 9.11
Funders
- Taipei Veterans General Hospital
- National Science and Technology Council